North Little Rock, ARNCT05889182Now EnrollingIRB Ready

Hidradenitis Suppurativa Clinical Trial in North Little Rock, AR

Access cutting-edge hidradenitis suppurativa treatment through this clinical trial at a research site in North Little Rock. Study-provided care at no cost to qualified participants.

Sponsored by AbbVie

Quick Self-Assessment

See if you qualify for this North Little Rock location

Preparing your pre-screening questions...

Expert Care in North Little Rock

Access hidradenitis suppurativa specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hidradenitis suppurativa treatment provided free

Apply for This North Little Rock Location

Check if you qualify for this hidradenitis suppurativa clinical trial in North Little Rock, AR

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to North Little Rock

    Convenient for AR residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit North Little Rock site if eligible
  4. 4Begin participation

About This Hidradenitis Suppurativa Study in North Little Rock

Hidradenitis suppurativa (HS) is an inflammatory skin disease that causes painful lesions in the axilla (underarm), inguinal (groin) and anogenital (anal/genital) regions. This study will assess how safe and effective upadacitinib is in treating adult and adolescent participants with moderate to severe HS who have failed to respond to or are intolerant of anti-tumor necrosis factor (TNF) therapy. Adverse events and change in disease activity will be assessed. Upadacitinib is an approved drug fo

Sponsor: AbbVie

Who Can Participate

Inclusion Criteria

Diagnosis of hidradenitis suppurativa (HS) for at least 6 months prior to Baseline, as determined by the investigator (i.e., through medical history and interview of participant).
Documented history of previous use of \>= 1 tumor necrosis factor (TNF) inhibitor for HS for at least 12 weeks and/or 1 approved non-anti-TNF biologic therapy for HS for at least 16 weeks characterized by inadequate response or for any duration characterized by intolerance as determined by the investigator.
Participant must have a total abscess and inflammatory nodule (AN) count of \>= 5 at Baseline.
HS lesions must be present in at least 2 distinct anatomic areas at Baseline.
At least 1 anatomic area of HS involvement characterized as Hurley Stage II or higher at Baseline.
Draining fistula count of \<= 20 at Baseline.

Exclusion Criteria

History of active skin disease other than HS that could interfere with the assessment of HS, including skin infections (bacterial, funga

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in North Little Rock?

Yes, this clinical trial (NCT05889182) has an active research site in North Little Rock, AR that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hidradenitis Suppurativa Treatment Options in North Little Rock, AR

If you're searching for hidradenitis suppurativa treatment options in North Little Rock, AR, this clinical trial (NCT05889182) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our North Little Rock research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hidradenitis suppurativa specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hidradenitis suppurativa clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in North Little Rock, AR

See all alzheimers disease clinical trials recruiting in North Little Rock — not just this study.

Browse Alzheimers Disease Trials in North Little Rock →

Browse More Trials by Condition

Alzheimers Disease TrialsRheumatoid Arthritis TrialsAtopic Dermatitis TrialsHidradenitis Suppurativa TrialsAll Conditions →

Ready to Join in North Little Rock?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · North Little Rock, AR